Commentary: Salt, blood pressure and health

G MacGregora and HE de Wardenerb

a Blood Pressure Unit, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. E-mail: gmacgreg{at}sghms.ac.uk
b Department of Clinical Chemistry, Imperial College of Technology and Medicine, Charing Cross Campus, St Dunstan's Road, London W6 8RP, UK. E-mail: h.dewardener{at}ic.ac.uk

The Yanomamo Indians still lead a life very similar to the last million or so years of our evolution,1 and like primitive man eat a diet that is very low in salt and saturated fat and high in fruit, vegetables and roots.2 The Yanomamo Indians are not overweight, do not smoke and are very fit. Their blood pressure does not rise with age although they spend much of their time fighting and are under great stress.3 This tribe does not develop vascular disease, although many die of infection. However, when they migrate to a Venezuelan or Brazilian town and adopt a western lifestyle, they, like native Americans, become overweight and develop diabetes and premature vascular disease. They appear therefore, to be a group which, though predisposed to vascular disease, is protected by the way they live. There are other similar examples4 which clearly indicate that cardiovascular disease (strokes, heart attacks and heart failure) could be entirely prevented if we changed our diet and lifestyle.

Approximately half of the population in the UK dies of cardiovascular disease5 yet very little is done to prevent this by changing lifestyle or diet. Clearly, much greater efforts are needed to try to understand what simple changes could have beneficial effects. To relate dietary variables such as salt, saturated fat, fruit and vegetable consumption to outcome is not easy because at present the intake of salt, fat, fruit and vegetables varies considerably from day to day, as does the blood pressure. Unfortunately it is not possible to set up dietary outcome experiments in which babies are randomized at birth, or ideally at conception, into one group that eats less salt or less fat and more fruit and vegetables, while another group continues on a ‘normal’ diet for life. Such experiments are never going to be done, we therefore have to rely on evidence from epidemiology, migration, intervention, treatment, animal and genetic studies. In spite of the difficulties of quantifying salt intake in an individual because of the variability of western diets and the variability of the blood pressure, the evidence that dietary salt is related to blood pressure, both in the rise that occurs with age and the number of people whose blood pressure is raised, is stronger than all other dietary variables.

Alderman has been one of the main proponents of the dangers of reducing salt intake. He encouraged the National Heart, Lung and Blood Institute (NHLBI) in the USA to set up a large workshop on sodium and blood pressure in January 1999 in order to critically review all of the current scientific evidence on salt. For reasons that are unclear Alderman did not attend the meeting which concluded that ‘a high sodium intake is associated with higher blood pressure levels, and other cardiovascular and non-vascular conditions continue to increase‘, and that ‘a population wide strategy of reducing salt in the food supply is an important public health strategy that can lower blood pressure among populations‘.5 Alderman's current overview of the subject is highly selective. He ignores over 40 careful studies in unacculturated human populations who at one time consumed, or continue to consume, less than 3 grams of salt per day.4 In these populations blood pressure did not and does not rise with age. Furthermore, there are other unacculturated populations which demonstrate that it is the low salt intake which is responsible for the lack of rise in blood pressure, not some other aspect of unacculturation.6,7 Alderman points out that Kuna Indians appear to be an exception8 to the general experience that a high salt intake is associated with a rise in blood pressure with age but he does not mention that in this study 24-h urinary sodium excretion was not measured. The estimation of salt intake relied in part on the recollection of how many teaspoons of salt each person had added to their food. One of the reasons the large InterSalt study9 was set up with careful attention to methodology, including 24-h urine collections, was precisely because of the difficulty of estimating salt intake from dietary history. Alderman also refers to an observational study in Italian nuns where the blood pressure did not rise with age10 but he does not quote the investigators' own conclusions. It appeared to them that in order to avoid the customary rise in blood pressure with age it is necessary to live in a stress free environment, characterized by total silence, continuous meditation and isolation from society. It is noticeable that although the first account of these nuns appeared 10 years ago the findings have never been confirmed elsewhere.11

The InterSalt study9 was set up to study a wide range of salt intakes across the world and measure blood pressure and other variables under well controlled conditions. By the time the study was completed there were only four communities who ate less than 3 grams of salt a day. The others were in a very narrow range of salt intake, approximately 7–12 grams of salt a day. The majority of these communities were eating a western diet in which salt intake varies so much from day to day that individual variations in sodium excretion may be considerable, e.g. more than five-fold.12 It follows that in many of these communities salt intake in any one individual might vary from day to day by the same amount as the variability between individuals. It is not surprising therefore that, in the InterSalt study, if one excludes the few communities who eat less than 3 grams of salt, and only considers those communities which consume between 7 and 12 grams of salt a day, there is no clear relationship with blood pressure. Alderman fails to point out that if all the communities are considered, there is a clear relationship between salt intake and blood pressure and the rise in blood pressure with age (Figure 1Go).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1 The relation of salt excretion to the slope of the rise in systolic blood pressure with age in 52 centres in the INTERSALT study. (Adapted from Ref. 9.)

 
The only intervention study that has successfully managed to reduce salt intake remains the Portuguese study where two villages were studied.13 One village was given information on how to reduce salt intake, particularly in relation to processed foods, and it was given processed foods with less salt. Salt intake was reduced by approximately 50%, as judged by 24-h urinary sodium. Over two years this resulted in substantial differences in blood pressure, compared to the control village where no reduction in salt intake was made (Figure 2Go).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 2 Blood pressure changes with time in two Portuguese villages, one of which was advised on how to reduce salt intake and given processed foods with a reduced salt content, the other had similar measurements of blood pressure but no advice on diet. Note the significant differences in blood pressure at 1 year and continuing differences at 2 years. (Adapted from Ref. 13.)

 
Perhaps it is understandable that Alderman all but ignores all the animal work that relates salt intake to blood pressure. He reduces it to one dismissive sentence. There are now numerous studies in the rat, dog, chicken, rabbit, baboon and chimpanzee, all of which have shown that when there is a prolonged increase in salt intake there is an increase in blood pressure.14 Furthermore in all forms of experimental hypertension, whatever the animal model, a high salt intake is essential for the blood pressure to rise. A recent study was carried out in chimpanzees,15 the nearest relative to humans (98.8% genetic-homology). The normal salt intake of a chimpanzee, which weighs up to 50 kg, is less than 0.5 gram a day. When it was increased to 15 grams a day the blood pressure rose slowly and the rise became significant after one year when it was still rising. Blood pressure returned to normal when the salt intake was reduced (Figure 3Go). These results show that if the animal species most closely related to humans, which normally consumes a diet as low in salt as the one it (and the human race) is genetically programmed to eat, increases its salt intake into the same range as that of present day humans, they, like humans, develop hypertension.



View larger version (52K):
[in this window]
[in a new window]
 
Figure 3 Blood pressure in chimpanzees who either continued on their usual diet (10 mmol sodium per day) or were given an increased salt intake (200 mmol sodium per day). At the end of the 20-month study, the salt supplements were stopped and blood pressure declined to that of the control group. (Adapted from Ref. 15.)

 
Alderman now concedes that when salt intake is reduced there is a fall in blood pressure in both normotensive and hypertensive humans. He even concedes that a fall of ‘a few millimetres of mercury if sustained, assuming the method of its achievement induces no harm, could produce more reductions in morbidity and mortality than is currently achieved by treating high blood pressure’. His ensuing comment that this ‘possibility energises advocates of sodium restriction’ presumably indicates that nevertheless Alderman wishes to distance himself from these findings. It could be put forward that this is a reasonable uncritical reaction to meta-analyses which have included studies of extremely large changes in salt intake over periods of less than one week.16 Such manoeuvres have been known to stimulate the sympathetic nervous system.17 The inclusion of such short term studies, particularly in normotensives, is inappropriate when the recommendations for public health are for a modest reduction in salt intake from 10 grams to 5 grams a day over a lifetime, not a few days. A more recent meta-analysis that only included studies of modest and longer term reductions in salt intake, showed that the fall in blood pressure in normotensives was greater18 than in the previous meta-analyses. In the most rigorous trial (DASH Sodium Study)19 in which there were several hundred participants, and the daily sodium intake was well controlled, the fall in pressure was even greater (Figure 4Go). There is evidence that the full effect of salt restriction may not be seen within a month so that with longer term reductions in salt intake there may well be greater falls in blood pressure. In other words, there is every indication that the recommendations of a modest reduction of salt intake from 10 grams to 5 grams a day over a prolonged period of time has a pronounced effect on blood pressure, not only in the hypertensives but also in the normotensive population.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 4 Changes in blood pressure and 24-hour urinary sodium excretion with the reduction in salt intake in all participants (hypertensives: n = 169; normotensives: n = 243) on the normal American diet (i.e. control diet) and on DASH diet. (Redrawn from Ref. 19.)

 
When discussing the other effects of ‘sodium restriction‘, Alderman forgets to mention that in addition to, and independent of, raising blood pressure, a high salt intake increases the mass of the left ventricular wall,20 stiffens conduit arteries21 and thickens and narrows resistance arteries,22 including the coronary23 and renal arteries.24 A high salt intake is also directly related to the number of strokes,25 severity of cardiac failure,26 adhesiveness of platelets,27,28 carcinoma of the stomach29 and, to bone demineralization.30 Alderman misunderstands the relationship of sodium intake to vascular compliance; he conveniently reverses it—what has been found is that a reduction in sodium intake increases vascular compliance.31 He rightly but ominously points out that salt intake is well documented to relate closely to the renin angiotensin system. It is true that the renin angiotensin aldosterone system is one of the major compensatory mechanisms that maintains blood pressure and reduces the excretion of sodium, and thus when extracellular volume is reduced with diarrhoea or diuretics there is a rise in plasma renin. This is an entirely normal physiological response, and to try to intimate that it is abnormal, and harmful, for plasma renin to rise in response to a reduction in extracellular volume, is extraordinary. The Yanomamo Indians, who still live an evolutionary form of life and have a very low salt intake (<0.5 g per day), have the highest renin and aldosterone levels measured. But they do not develop vascular disease. According to Alderman's hypothesis, such high levels of angiotensin and aldosterone should precipitate an acceleration of vascular disease at an early age. Animal experiments, however, have shown that it is the appropriateness of the level of renin and aldosterone to the blood volume or extracellular volume that may cause damage, not the absolute level of plasma renin activity angiotensin II or aldosterone.32,33 There are experiments in animals that demonstrate that salt loading per se has identical effects to that of giving aldosterone or angiotensin II.22,34,35 In other words, the deleterious effect of aldosterone on cardiac fibrosis, etc, appears to be due to the associated retention of an excess amount of salt and water.

In view of Alderman's belief in the dangers of an increase in renin and aldosterone, it is surprising that he supports the use of diuretics for the treatment of hypertension.36 Diuretics have been shown to be very effective in reducing cardiovascular disease, i.e. strokes, heart failure and coronary artery disease, particularly in the elderly, but they cause increases in plasma renin activity and aldosterone which, according to Alderman, should be harmful. A modest reduction in salt intake lowers blood pressure in an identical way to diuretics and increases both renin and aldosterone to the same levels. Alderman needs to explain why he considers diuretics to be so beneficial, and yet according to him salt restriction is not.

Whilst it is true that non-acculturated societies have shorter life spans, this is not due to an increase in the incidence of cardiovascular disease, which they almost totally avoid, but to the greater risk of infection, particularly when exposed to western populations. It is true that the Japanese are an example of a society that has a longer life expectancy than many of those in the west. As the Japanese have a high salt intake, Alderman suggests that this illustrates that salt intake is not related to life expectancy. But the Japanese did not, and to a large extent still do not, eat much fat and they have a low plasma cholesterol37 which protects them from the development of vascular disease and atherosclerosis. Alderman fails to point out that the major causes of death in Japan are cerebral haemorrhage38 and cancer of the stomach,29 both of which are due to the high salt intake. Indeed, he appears to be unaware that in the 1960s there was a government campaign in Japan to reduce salt intake. It was successful in lowering blood pressure and causing large reductions in stroke mortality.39 It is very likely that if the Japanese were to reduce their salt intake further, whilst continuing to eat a minimum amount of saturated fat, they would live even longer than they do now.

Alderman fails to mention the North Karelia project in northern Finland where the incidence of cardiovascular disease was very high. In co-ordination with the food industry, a government-backed campaign has been successful in reducing salt and fat intake, increasing fruit and vegetable consumption and cutting cigarette smoking. This has resulted in a reduction in blood pressure and fat intake and significant falls in stroke and coronary heart disease mortality.40,41 Three-quarters of the fall in coronary heart disease and two-thirds of the fall in stroke mortality were due to the change in risk factors. This study clearly indicates that if we were prepared to change our lifestyle, particularly our diet, major reductions in cardiovascular mortality could ensue.

In a final attempt to obfuscate, Alderman once more revives the myth42 that a moderate reduction in salt intake is harmful. He again quotes completely inappropriate experiments in which the sodium intake of rats was so low that it stunted growth.43 The intake of sodium was lower than occurs naturally in mammals eating only fruit and vegetables. Therefore when discussing the possible effects of reducing salt intake from approximately 10 grams to 5 grams a day such experiments are irrelevant. For instance, in comparative terms, a reduction in salt intake to 5 grams a day, which has been suggested for humans at present, is about a thousand times less of a reduction than that used in the animal studies he is quoting.

Alderman's other attempts to suggest that a low salt intake is dangerous in humans are based on two of his own publications in which a claim is made that there is a relationship between habitual salt intake and myocardial infarction.44,45 The data on sodium excretion in the first paper and of sodium intake in the second are so seriously flawed however, that the claim is unacceptable. In the first study, 24-h urine collections were made in 3000 treated hypertensives after 5 days of salt restriction, imposed in order to stimulate the renin-angiotensin system so that the patients could be classified into high, normal and low renin sub-groups. Therefore, these 24-h urinary sodium excretion collections bore no relationship to the patient's habitual salt intake. Despite this, Alderman continues to claim falsely that the urine was collected when the patients were on their habitual salt intake. In addition to this false statement on the nature of the diet the patients were supposed to be eating, Alderman and his colleagues' estimate of the dietary sodium that the patients were consuming, which was based on a 24-h urine collection, was also inaccurate. The 3000 patients were divided into four groups depending on the 24-h urinary sodium excretion. It was noticeable that the sodium excretion paralleled creatinine clearance which strongly suggested that there had been problems with urine collections. But as creatinine excretion had not been given it was not possible to be certain. Subsequently, however, Dr Alderman released the data on creatinine excretion. This should be relatively constant and unaffected by glomerular filtration but it rose with the creatinine clearance which confirmed that there had been serious problems with urine collections. This conclusion was re-enforced by the urine volume and potassium excretion which also followed creatinine excretion. In other words, because of inaccurate urine collections, many patients and their results had been classified into spurious sodium excretion quartiles and not into true sodium intake quartiles. One can conclude therefore that the claim that an habitual low salt intake in hypertensive patients is inversely related to myocardial infarction cannot be sustained.

In Alderman's second paper, a 24-h dietary recall on nutrient intake was used to gauge the habitual salt intake of sodium and calories in more than 10 000 subjects between 1971 and 1975. The subjects were then re-examined 20 years later. The calculation of sodium intake, which was based on dietary recall, took no account of discretionary salt intake, i.e. salt added by an individual at the table or in his own cooking which, around 1980, would have accounted for approximately half of salt intake. The measurement of salt intake in this study is therefore inaccurate. A simple inspection of the overall results of the paper also reveals that these are insecure. For instance, Engleman46 pointed out that in the lowest quartile of daily salt intake in both men and women (approximately 1 and 2 grams respectively) calorie intake was 50% lower than the national recommended daily dietary allowance. Karppanen and Mervaala47 commented that they thought it remarkable that on such a near starvation diet there were so many survivors. They thought it should have surprised, even Alderman, that women on this extraordinary low calorie intake were on average 4 kilograms heavier than those in the higher sodium quartile, who were apparently eating twice as many calories. The misrepresentation of habitual salt intake which resulted from faulty urine collections in the first paper and the defective questionnaire data on sodium and calorie intake in the second paper invalidate any claim that a low sodium intake is related to myocardial infarction. Recent evidence from Finland shows that there is a clear relationship between mortality and salt intake (Figure 5Go).48 Unfortunately for Alderman's argument it shows that the higher the salt intake the greater the mortality.



View larger version (41K):
[in this window]
[in a new window]
 
Figure 5 The hazards ratios for coronary heart disease (CHD), cardiovascular disease (CVD), and all-cause mortality associated with a 6 g/day increase in salt intake as judged by 24-hour urinary sodium excretion. (Adapted from Ref. 40.)

 
Salt was only discovered by humans about 5000 years ago when it was found to have the magical property of preserving food.1 It therefore became of great importance in the development of settled communities and civilizations.49 Now, however, with the development of the deep freeze and refrigerator, salt is no longer required for preservation. Unfortunately, with the development of processed foods, salt has once again become of great commercial importance, not only to the salt manufacturers and extractors, but also to the food and soft drinks industries. Many of the cheap processed foods are only palatable with the addition of large amounts of salt, the cheapest ingredient. When people are exposed to foods which contain high concentrations of salt the salt taste receptors are suppressed. The individual therefore becomes habituated to this type of food, which increases the demand for highly salted processed foods. Salt is also very important to the processed meat industry, for a higher salt concentration increases the water binding capacity. In this way the weight of the product can be raised by 10 to 20% at no cost to the producer. Total salt intake is an important stimulus to thirst and therefore fluid consumption.50 Any reduction in the population's salt intake will have a large effect on soft drinks, mineral water and beer consumption.50

It is not surprising, therefore, that commercial interests which represent the salt manufacturers and extractors, e.g. the Salt Institute in the US and the soft drinks industry, together with many sections of the food processing industry, have co-operated in perpetuating the idea that salt is not involved in hypertension. They have also suggested that dietary salt only effects a small number of people and that therefore it is not worthwhile for the normotensive population to reduce its salt intake. They also perpetuate the myth that reducing salt intake can be dangerous.

Alderman has acted as a member of the Medical Advisory Board for the Salt Institute51 in the US, which represents the salt manufacturers and extractors not only in the US but world-wide. The Institute kindly distributed his paper in which the claim was made that salt intake was related to myocardial infarction as a ‘professional courtesy’. At the same time the Institute put out a news release which claimed that this study unequivocally ‘showed that hypertensives consuming low sodium diets had dramatically increased rates of having heart attacks'. This so-called evidence formed the main plank of the Salt Institute's aborted petition52 to the FDA to try to change the regulations concerning commercial claims for low salt foods. Alderman was one of the co-signatories of this petition.

When all of the evidence is considered from epidemiological, migration, intervention, treatment trials, genetic studies in humans and animal studies that relates salt intake to blood pressure and other harmful effects, the evidence is very strong. It is stronger than evidence for other dietary variables that are also important in cardiovascular disease, e.g. saturated fat intake and fruit and vegetable consumption. Nearly all government appointed bodies and nutrition experts who have considered the evidence have recommended a reduction in salt intake from around an average consumption of 10–12 grams to 5–6 grams per day. This recommendation was made in the US in 1970 and in the UK in 1994. Nevertheless salt intake is increasing due to the much greater consumption of processed and ready prepared foods which are very high in salt, often equivalent to that of seawater. In the UK there is a strategy to make small, i.e. 10 to 25%, reductions in the salt concentration of all processed foods. These reductions will not be detected by the consumer and as the salt taste receptors get used to the lower concentration, further reductions can be made in four or five years time. In this way salt intake could be reduced throughout the population without the consumer having to reduce their salt intake consciously. However, the reduction would be greater if consumers themselves added less salt to the food both in cooking and at the table. In this way it should be possible to reduce salt intake in the Western world by half over the next decade. Of all the dietary strategies to reduce the intake of salt, this is probably the easiest to achieve, provided the food industry is prepared to co-operate. In the UK, by manoeuvres which resemble those employed by the tobacco industry, such steps are being vigorously opposed by the Salt Manufacturers' Association and the Food and Drink Federation, an umbrella organization representing the soft drinks, the snack producers (many of which are owned by the soft drinks producers) and other food processors.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6 The commercial importance of salt in processed food

 
References

1 Eaton SB, Konner M. Paleolithic nutrition. N Engl J Med 1985;312: 283–88.[ISI][Medline]

2 Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake and sodium related hormones in Yanomamo Indians, a ‘no-salt’ culture. Circulation 1975;52:146–51.[Abstract]

3 Chagnon NA. Yanomamo. The Fierce People. New York: Holt, Rinehart & Winston, 1968.

4 Denton D. The Hunger for Salt. Heidelberg: Springer Verlag, 1982.

5 Chobanian AV, Hill M. National Heart Lung and Blood Institute Workshop on sodium and blood pressure. A critical review of current scientific evidence. Hypertension 2000;35:858–63.[Free Full Text]

6 Page LB, Damon A, Moellering RC. Antecedents of cardiovascular disease in six Solomon Island societies. Circulation 1974;49:1132–46.[ISI][Medline]

7 Page LB, Vandevert DE, Nader K et al. Blood pressure of Quash‘qai pastoral nomads in Iran culture, diet and body form. Am J Clin Nutr 1981;34:527–38.[Abstract]

8 Preston M, Rivera A, Taplin D, Vicaria-Clement M. Ageing, acculturation, salt intake and hypertension in the Kuna of Panama. Hypertension 1997;29:171–76.[Abstract/Free Full Text]

9 The Intersalt Study. J Hum Hypertens 1989;3:179–330.[ISI][Medline]

10 Timio M, Lippi G, Venanzi S et al. Blood pressure trend and cardiovascular events in nuns in a secluded order: A 30 year follow-up study. Blood Press 1997;6:81–87.[Medline]

11 Timio M, Verdecchia P, Venanzi S et al. Age and blood pressure changes. A 20-year old follow-up study in nuns in a secluded order. Hypertension 1988;12:457–61.[Abstract]

12 Siani A, Lacoviello L, Giorgione N, Lacone R, Strazzullo P. Comparison of variability in urinary sodium, potassium and calcium in free living man. Hypertension 1989;13:38–42.[Abstract]

13 Forte JG, Pereira Miguel JM, Pereira Miguel MJ, de Padua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens 1989;3: 179–84.[ISI][Medline]

14 Wardener de HE, MacGregor GA. Blood pressure and the kidney. In: Schrier RW (ed.). Diseases of the Kidney and Urinary Tract. 7th Edn. Philadelphia: Lippincott Williams and Wilkins, 2001, pp.1329–61.

15 Denton D, Weisinger R, Mundy NI et al. The effect of increased salt intake on blood pressure of chimpanzees. Nature Med 1995;1:1009–16.[ISI][Medline]

16 Midgley JP, Matthew AG, Greenwood CMI, Logan AG. Effect of reduced dietary sodium on blood pressure in a meta-analysis of randomized controlled trials. JAMA 1996;275:1590–97.[Abstract]

17 Romoff MS, Keush G, Campese VM et al. Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrin Metab 1978;48:26–29.[ISI][Medline]

18 He F, MacGregor G. Effect of longer-term modest reduction on blood pressure. A meta-analysis. Implications for public health. J Hum Hypertens 2000;18(Suppl.4):S126 (Abstract).

19 Sacks RM, Svetkey LP, Vollimer VM et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001;344:3–10.[Abstract/Free Full Text]

20 Schmieder RE, Messerli FH. Hypertension and the heart. J Hum Hypertens 2000;14:597–604.[CrossRef][ISI][Medline]

21 Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium to large artery structure and formation in hypertension. Cardiovasc Res 2000;46:269–76.[CrossRef][ISI][Medline]

22 Simon G, Illyes G. High sodium diet induces structural vascular changes in rats without raising blood pressure. Am J Hypertens 2000; 13:B001.

23 Lenda DM, Sauls BA, Boegehold MA Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol 2000;279:H7–H14[Abstract/Free Full Text]

24 Vaskonen T, Mervaala E, Krogerus L et al. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Hypertens Res 1997;20:183–92.[Medline]

25 Perry I, Beevers DG. Salt intake and stroke: a possible direct effect. J Hum Hypertens 1992;6:23–25.[ISI][Medline]

26 Frolich ED. Risk mechanisms in hypertensive heart disease. Hypertension 1999;34:782–89.[Abstract/Free Full Text]

27 Gow IF, Dockrell M, Edwards CR et al. The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy men. Eur J Clin Pharmacol 1992;43:635–38.[ISI][Medline]

28 Gow IF, Padfield PL, Reid M, Stewart SE, Edwards CR, Williams BC. High sodium intake increases platelet aggregation in normal females. J Hypertens 1987;5(Suppl.5):S243–46.

29 Joossens JV, Hill MJ, Elliott P et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996;25:494–504.[Abstract]

30 MacGregor GA, Cappuccio FP. The kidney and essential hypertension: a link to osteoporosis. J Hypertens 1993;11:781–85.[ISI][Medline]

31 London GM, Safar ME, Safar AL, Simon AC. Blood pressure in the ‘low pressure system’ and cardiac performance in essential hypertension. J Hypertens 1985;3:337–42.[ISI][Medline]

32 Simon G, Illyes C, Csiky B. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure and time. Hypertension 1998;32:654–60.[Abstract/Free Full Text]

33 Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272–79.[ISI][Medline]

34 Fields NG, Yuan B, Leenen FHH. NaCl-induced cardiac hypertrophy: cardiac sympathetic activity versus volume load. Circ Res 1991;68: 745–55.[Abstract]

35 Kihara M, Utagawa N, Mano M, Nara Y, Horie R, Yamori Y. Biochemical aspects of salt-induced pressure-independent left ventricular hypertrophy in rats. Heart Vessels 1985;1:212–15.[Medline]

36 Alderman MH. Which antihypertensive drugs first—and why! JAMA 1992;267:2786–87.[CrossRef][ISI][Medline]

37 Ueshima H, Lida M, Shimamoto T et al. Dietary intake and serum total cholesterol level: their relationship to different lifestyles in several Japanese populations. Circulation 1982;66:519–26.[Abstract]

38 Sasaki N, Takeda J, Fukushi S et al. On nutritional factors related to geographical difference in death rate from apoplexy in Japan. Jpn J Public Health 1960;7:1137–43.

39 Sasaki N. The salt factor in apoplexy and hypertension: epidemiological studies in Japan. In: Yamori Y (ed.). Prophylactic Approach to Hypertensive Diseases. New York: Raven Press, 1979, pp.467–74.

40 Tuomilehto J, Jousilahti P, Rastenyte D et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848–51.[CrossRef][ISI][Medline]

41 Karppanen H, Mervaala E. Adherence to and population impact on non-pharmacological and pharmacological anti hypertensive therapy. J Hum Hypertens 1996;10(Suppl.1):S57–S61.[ISI][Medline]

42 Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 urinary sodium and potassium excretion. BMJ 1988;297: 319–28.[ISI][Medline]

43 Toal CB, Leenen HH. Dietary sodium restriction and development of hypertension in spontaneously hypertensive rats. Am J Physiol 1983; 245:1081–84.

44 Alderman MH, Madhaven S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995;25: 1144–52.[Abstract/Free Full Text]

45 Alderman MH, Cohen H, Madhaven S. Dietary sodium intake and mortality. The National Health and Nutrition Examination Survey (NHANES 1). Lancet 1998;351:781–85.[CrossRef][ISI][Medline]

46 Engelman K. Sodium intake and mortality (Letter) Lancet 1998;351: 1508.[CrossRef][Medline]

47 Karppanen H, Mervaala E. Sodium intake and mortality (Letter) Lancet 1998;351:1509.[Medline]

48 Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848–51.[CrossRef][ISI][Medline]

49 Adshead SAM. Salt and Civilization. London: MacMillian Academic and Professional Ltd, 1992.

50 He FJ, Markandu ND, Sagnella GA, MacGregor GA. Effect of salt intake on renal excretion of water in humans. Hypertension 2001;38:317–20.[Abstract/Free Full Text]

51 Alderman M. Dietary sodium and blood pressure. N Engl J Med 2001; 344:3–10.[Abstract/Free Full Text]

52 Salt Institute Petition to the Food & Drug Administration, September 19, 1996.